A protective role for the cerebellum in cognitive aging

Federico d'Oleire Uquillas,Esra Sefik,Jakob Seidlitz,Jewel Merriman,Veronica Zhang,Jonathan D Cohen,Rafael Romero-Garcia,Varun Warrier,Richard A.I. Bethlehem,Aaron F Alexander-Bloch,Jorge Sepulcre,Samuel S.-H. Wang,Patrizia Vannini,Jesse Gomez
DOI: https://doi.org/10.1101/2024.10.15.618102
2024-10-17
Abstract:Background: Brain reserve - the brain's resilience to age-related change or damage - provides protection against cognitive decline. The cerebellum is relatively unstudied as a contributor to brain reserve. This study investigates cerebellar brain reserve in the largest cohort to date. Methods: We used data from the Human Connectome Project (n=708, 36-100yrs), UK Biobank (n=45,013, 44-81yrs), and ADNI (n=1,423, 56-95yrs). ADNI participants were cognitively normal or had a diagnosis of mild cognitive impairment or Alzheimer's disease (AD) dementia. We examined associations between cerebellar tissue volume, age, Montreal Cognitive Assessment (MoCA) scores, global PET amyloid burden, and APOE genotype. Findings: HCP-Aging data revealed heterogenous aging-associated changes in cerebellar volume, with the greatest effects in posterior hemispheric regions (crus I) (Bonferroni-corrected, p<0.05). MoCA scores were associated with higher tissue density in the cerebellum (p<0.0001) to the same extent as neocortex, and MoCA scores coupled most strongly with posterior cerebellar cortex. Strikingly, greater volume in MoCA visuospatial-related cerebellar cortex protected against aging-related cognitive decline (p=0.0001). We replicated tissue aging results in the UK Biobank with the greatest aging-related effects in posterior cerebellum (p<0.0001), and an association of greater cerebellar volumes with less cognitive decline (Trails Making-B: p<0.00001; Digit Symbol Substitution: p=0.034). AD patients with low amyloid-beta burden (AB-) exhibited the strongest cerebellar association with MoCA (volume x group, AB- AD: p=0.0001). In AB- individuals, APOE e4/e4 carriers showed the greatest effect with MoCA (volume x APOE, e4/e4: p=0.017). Interpretation: Our large-scale study demonstrates a potentially strong role for the cerebellum in mitigating cognitive decline. The persistence of this protection in APOE e4 carriers reshapes our understanding of reserve and AD risk. Our findings open the cerebellum as a novel target for future clinical research on brain reserve in aging populations. Funding: National Science Foundation, National Academies of Sciences, Engineering and Medicine, National Institutes of Health.
Neuroscience
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the protective role of the cerebellum in cognitive aging. Specifically, the research aims to: 1. **Explore whether the cerebellum shows spatial heterogeneity**: Do different regions of the cerebellum show different changes as age increases? 2. **The relationship between cerebellar aging and individual cognitive scores**: Is the change in cerebellar volume related to an individual's cognitive performance? 3. **The manifestations of these processes in clinical conditions such as Alzheimer's disease (AD) dementia**: How does the cerebellar structure predict cognitive performance and interact with amyloid - β brain pathology and APOE genotype, especially in individuals with low amyloid - β brain burden and high AD risk? By using large - scale neuroimaging data sets from the Human Connectome Project (HCP - Aging), the UK Biobank, and the Alzheimer's Disease Neuroimaging Initiative (ADNI), researchers hope to reveal the potential protective mechanisms of the cerebellum in cognitive aging and its role in healthy aging and in patients with mild cognitive impairment or AD. This research not only helps to understand the role of the cerebellum in cognitive aging but may also provide new targets for future clinical research.